AKT1 and neoplasm: In the present study, using both mouse primary and tumor Leydig cells, we further explored how FGF9 could activate JNK, p38, ERK1/2, and Akt, which are the downstream signal transduction mediators of the Ras/MAPK and PI3K pathways.